The leishmaniases are diseases caused by pathogenic protozoan parasites of the genus
Leishmania. Infections are initiated when a sand fly vector inoculates Leishmania parasites …

Tegumentary leishmaniasis, comprising the cutaneous and mucocutaneous forms, is
caused by at least 13 dermotropic species of protozoa of the genus Leishmania, most of …

It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

Pentavalent antimonials are first-line drugs for the treatment of the cutaneous form of
American tegumentary leishmaniasis. Second-line drugs include amphotericin B and …

The prevalence and intensity of infections caused by protozoa, nematodes, trematodes,
cestodes, and arthropods is higher in males than females. The primary thesis of this review …

Leishmaniasis is a neglected tropical disease that affects 12 million people worldwide. The
disease has high morbidity and mortality rates and is prevalent in over 80 countries, leaving …

Leishmaniases remain a major public health problem today despite the vast amount of
research conducted on Leishmania pathogens. The biological model is genetically and …

One hundred fourteen Leishmania isolates from patients with different clinical forms of
leishmaniasis in the State of Bahia, Brazil, were characterized by indirect radioimmune …

We performed a systematic review of the literature published since 1900 about
leishmaniasis a neglected vector-borne disease, focused on environmental and social risk …

Background Cutaneous leishmaniasis (CL) is treated with parenteral drugs for decades with
decreasing rate cures. Miltefosine is an oral medication with anti-leishmania activity and …